183 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... #HeartFailure #Management ... #CHF #guideline ... #ACCAHA2017 #cardiology ... #treatment #algorithm
Causes of Hemoptysis - Differential Diagnosis Algorithm
Massive Hemoptysis (>I00 mL in 24 hours)
 • Malignancy
 •
- Differential Diagnosis ... Algorithm Massive ... Hemoptysis (>I00 mL ... Abnormalities • CHF ... #Algorithm #Causes
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
Guidelines for Management ... #GCA #ACR2021 #Management ... #rheumatology # ... algorithm #vasculitis
Management of adult IgA Vasculitis (Henoch-Schönlein purpura) - Treatment algorithm for the management of IgAV patients
Management of adult ... purpura) - Treatment algorithm ... for the management ... #Treatment #Rheumatology ... #Vasculitis #Algorithm
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
and Treatment Algorithm ... Diagnosis: Ferritin ... iron #deficiency #CHF ... #management #algorithm ... #cardiology #treatment
2021 ACR/VF Guidelines for Management of Polyarteritis Nodosa (PAN)

#PAN #Polyarteritis #Nodosa #ACR2021 #Management #rheumatology #algorithm #vasculitis
Guidelines for Management ... Nodosa #ACR2021 #Management ... #rheumatology # ... algorithm #vasculitis
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
disorders • Diagnosis ... and Treatment Algorithm ... Syndrome #HES #Hematology ... #eosinophils #diagnosis ... #management #algorithm
Approach to Leukocytosis - Differential Diagnosis Algorithm

Features of hematologic malignancy:
 • Symptoms: B-symptoms, bruising/bleeding, fatigue/weakness, immunosuppression
- Differential Diagnosis ... Algorithm Features ... of hematologic ... Labs: anemia, ↑ MCV ... #Algorithm #hematology
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
Guidelines for Management ... Polyangiitis #ACR2021 #Management ... #rheumatology # ... algorithm #vasculitis
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF ... ventricular hypertrophy; MCS ... #CHF #Congestive ... Stages #ACCAHA #Algorithm ... #Management #Cardiology